Volume 123, Issue 1 , Pages 179-186, January 2009
Cytokine milieu modulates release of thymic stromal lymphopoietin from human keratinocytes stimulated with double-stranded RNA
Background
Thymic stromal lymphopoietin (TSLP) plays a key role in allergic diseases, such as atopic dermatitis (AD) and asthma. TSLP is highly expressed by keratinocytes in skin lesions of patients with AD, but environmental triggers for its release from keratinocytes with endogenous factors are not well understood. Patients with AD, in whom allergic sensitization is already established, are susceptible to viral dissemination.
Objectives
We investigated TSLP's release from primary human keratinocytes stimulated with a Toll-like receptor (TLR) 3 ligand, polyinosinic-polycytidylic acid, which mimics viral double-stranded RNA (dsRNA), and its modulation by cytokines.
Methods
Primary human keratinocytes were stimulated with TLR ligands, cytokines, or both. TSLP released into culture supernatants was measured by means of ELISA.
Results
Stimulation of keratinocytes with dsRNA induced release of TSLP and upregulated gene expression of TSLP and other cytokines and chemokines. The release of TSLP was enhanced by the addition of IL-4, IL-13, and/or TNF-α. With or without the TH2/TNF cytokines, the dsRNA-induced release of TSLP was upregulated by IFN-α and IFN-β and suppressed by IFN-γ, TGF-β, or IL-17.
Conclusions
The effect of the TLR3 ligand on keratinocytes suggests contribution of viral dsRNA to skin inflammations under the influence of a cytokine milieu. The results imply that viral dsRNA and a TH2 cytokine milieu might promote TH2-type inflammation through an induction of TSLP expression, suggesting that a vicious cycle exists between AD with TH2-type inflammation and viral infections and a possible blockade of this cycle by other cytokine milieus provided by cells, such as TH1, regulatory T, and TH17 cells.
Key words: Thymic stromal lymphopoietin, keratinocyte, double-stranded RNA, cytokine milieu, atopic dermatitis, viral exposure, viral infection, vicious cycle, promotion and blockade
Abbreviations used: AD, Atopic dermatitis, DC, Dendritic cell, dsRNA, Double-stranded RNA, Pam3CSK4, (S)-[2,3-Bis(palmitoyloxy)-(2-RS)-propyl]-N-palmitoyl-(R)-Cys-(S)-Ser-(S)-Lys4-OH, 3HCl, poly I:C, Polyinosinic-polycytidylic acid, TLR, Toll-like receptor, Treg, Regulatory T, TSLP, Thymic stromal lymphopoietin
Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.
PII: S0091-6749(08)01848-4
doi:10.1016/j.jaci.2008.10.008
© 2009 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 123, Issue 1 , Pages 179-186, January 2009
